On the other hand, in adult acute myeloid leukemia a multivariate analysis showed that expression of BCL-XL was found as an independent negative prognostic factor for response to induction of therapy in patients older than 60 years with intermediate cytogenetic risk [91]. Here, BCL2L1 is linked to acute myeloid leukemia.